National Vision Holdings Inc (EYE) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jul 04 2026 to Jun 28 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
National Vision Holdings Inc   (NASDAQ: EYE)


National Vision Holdings Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is National Vision Holdings Inc's ROI in the second quarter of 2026?
National Vision Holdings Inc achieved a return on average invested assets (ROI) of 4.09 % in its second quarter of 2026, this is above EYE's average return on investment of 1.34%.
National Vision Holdings Inc invested over the 12 months ending in its second quarter of 2026 $1,229 million

ROI decreased relative to the period ending Apr 04 2026, due to the decline in net income.

Within the Healthcare sector 157 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jul 04 2026 quarter, so far to 1927, from total ROI ranking in the first quarter of 2026 at 2468.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jul 04 2026)
II. Quarter		 (Apr 04 2026)
I. Quarter		 (Jan 03 2026)
IV. Quarter		 (Sep 27 2025)
III. Quarter		 (Jun 28 2025)
II. Quarter
Y / Y Investment Change TTM 13.19 % 4.68 % -1.22 % -6.52 % -12.23 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1,600 1,123 1,099 1,095 1,106
Return On Investment (TTM) 4.09 % 4.21 % 2.7 % -0.21 % -1.3 %
EYE's Overall Ranking # 1927 # 2468 # 2567 # 2674 # 2757
Seq. Investment Change TTM 11.17 % 0.97 % 0.78 % 0.06 % 2.81 %
Seq. Net Income Change TTM 7.92 % 57.42 % - - -
Net Income (TTM) in Millions 50 47 30 -2 -14

EYE Company Profile >> Back to EYE Roi Comparisons >> See Annual EYE Return On Investment



Return On Investment EYE's Ranking
Within: No.
Industry # 52
Sector # 158
Overall # 1927

Return On Investment Statistics
High Average Low
7.54 %
1.34 %
-4.71 %
(Oct 02 2021)   (Jun 29 2024)







Financial Statements
National Vision Holdings Inc's II. Quarter Investments $ 1,600 Millions EYE's Balance sheet
National Vision Holdings Inc's II. Quarter Income $ 12 Millions Quarterly EYE's Income Statement
EYE's Income by Division See EYE's Income by Division


EYE Annual Return On Investment (Jan 03 2026)
2025		 (Dec 28 2024)
2024		 (Dec 30 2023)
2023		 (Dec 31 2022)
2022		 (Jan 01 2022)
2021
Total Investments in Millions 1,099 1,065 1,280 1,465 1,501
Y / Y Investment Growth 3.18 % -16.81 % -12.59 % -2.43 % -4.74 %
Net Income in Millions 30 -28 -66 42 128
Y / Y Net Income Growth - - - -67.15 % 253.51 %
Annual Return On Investment 2.69 % -2.68 % -5.15 % 2.88 % 8.54 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 2.69 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EYE's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EYE's Competitors
Subscribers only: Roi for National Vision Holdings Inc's Suppliers
Subscribers only: Return On Investment for EYE's Customers

Other Ratios
EYE's Roa EYE's Inventory Turnover Ratio EYE's Growth Rates EYE's Dividend Statistics
EYE's Profitability Ratios EYE's Asset Turnover Ratio EYE's Dividend Growth
EYE's Roe EYE's Valuation Ratios EYE's Financial Strength Ratios EYE's Dividend Payout Ratio



Companies with similar Return On Investment at Jul 04 2026, within Healthcare Sector ROI
Embecta Corp   11.20 %
Lemaitre Vascular Inc   11.20 %
3m Company  11.16 %
Globus Medical Inc   11.01 %
National Healthcare Corp  10.91 %
Bioventus Inc   10.85 %
Infusystem Holdings Inc  10.53 %
Livanova Plc  10.40 %
Beone Medicines Ltd   10.32 %
Entrada Therapeutics Inc   10.15 %
Jazz Pharmaceuticals Plc  10.06 %
Prestige Consumer Healthcare Inc   10.06 %
Tactile Systems Technology Inc   10.02 %
Tenet Healthcare Corp  9.98 %
Nature s Sunshine Products inc   9.91 %
Boston Scientific Corporation  9.91 %
Align Technology inc   9.50 %
Pediatrix Medical Group Inc   9.18 %
Abbvie Inc   9.11 %
Ani Pharmaceuticals Inc  9.09 %
Viemed Healthcare Inc   8.97 %
Stryker Corp  8.80 %
Penumbra Inc  8.71 %
Utah Medical Products Inc  8.70 %
Edwards Lifesciences Corporation  8.39 %
Veracyte Inc   8.15 %
Phibro Animal Health Corporation  8.11 %
Brightspring Health Services Inc   8.05 %
Quest Diagnostics Inc  8.05 %
Addus Homecare Corp  7.98 %

Date modified: 2026-09-08T17:40:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.